Trials / Unknown
UnknownNCT04460443
Sofosbuvir in Treatment of COVID 19
Sofosbuvir Based Regimens in Treatment of COVID 19 Patients
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
Detailed description
Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sofosbuvir | Sofosbuvir once daily |
| DRUG | Sofosbuvir ledipsavir | Sofosbuvir ledipsavir once daily |
| DRUG | Daclatasvir | Daklatasuvir tablets |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2021-08-01
- Completion
- 2021-08-31
- First posted
- 2020-07-07
- Last updated
- 2020-12-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04460443. Inclusion in this directory is not an endorsement.